Aktiesnakken — Juli 2010
-
Vil det her ikke have negativ
indflydelse på GEN http://www.proinvestor.com/finansnyhed/10258059/GSK:-Avandia-salg-styrtdykker -
her er lidt om bioporto og lindblad:http://www.business.dk/navne/fyret-direktoer-med-mange-jern-i-ilden
-
det har ingen indflydelse - GEN er fuldt ud i stand til at skabe sine egne dårlige nyheder...
-
shit happens - og de kunne godt finde på nogle mere mundrette navne til medikamenterne
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
